What Does the Sale of Progyny Shares by the CFO Mean for Investors?

1 day ago 7

Robert Izquierdo, The Motley Fool

Thu, June 25, 2026 astatine 12:25 PM CDT 4 min read

Mark S. Livingston, Chief Financial Officer of Progyny (NASDAQ:PGNY), reported the merchantability of 8,275 shares of communal banal successful an open-market transaction connected May 20, 2026, arsenic disclosed successful an SEC Form 4 filing.

Transaction summary

Transaction worth based connected SEC Form 4 reported terms ($25.50); post-transaction worth based connected May 20, 2026 trade-date adjacent price.

Key questions

  • How meaningful was this merchantability arsenic a proportionality of Livingston's nonstop holdings?
    This transaction represented 9.47% of Livingston's nonstop position, a mean simplification accordant with the cadence of his anterior open-market sales.

  • Did the merchantability impact indirect oregon derivative holdings?
    No indirect oregon derivative holdings were reported; the enactment was constricted to straight held communal shares, leaving Livingston with 79,063 shares post-transaction.

  • What does the transaction uncover astir selling cadence and capacity?
    Recent income person corresponded to a diminution successful full disposable shares, with remaining nonstop holdings present astatine 43.2% of the level held successful July 2023, indicating that commercialized size reductions are a relation of reduced capableness alternatively than a alteration successful selling intent.

Company overview

* 1-year show metrics are calculated utilizing May 20th, 2026 arsenic the notation date.

Company snapshot

  • Progyny offers fertility and household gathering benefits solutions, including differentiated program designs, subordinate enactment services, a selective web of fertility specialists, and an integrated pharmacy benefits platform.

  • It operates a benefits absorption model, generating gross done employer-sponsored wellness payment programs and pharmacy solutions.

  • The institution serves employers crossed the United States seeking fertility and family-building benefits for their employees.

Progyny is simply a starring supplier of fertility and household gathering benefits, leveraging a data-driven level and selective supplier web to present tailored solutions for employers. The company's integrated attack combines program design, subordinate support, and pharmacy management, positioning it arsenic a differentiated subordinate successful the healthcare benefits space.

What this transaction means for investors

The May 20 merchantability of Progyny banal by CFO Mark Livingston came astatine a clip erstwhile shares were connected the upswing. His disposition astatine $25.50 per stock was adjacent to the 52-week precocious of $28.75 reached successful January. He subsequently sold further shares successful June.

Read Entire Article